+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Precision Medicine Market 2021-2028

  • ID: 5306592
  • Report
  • March 2021
  • Region: Global
  • 287 pages
  • Triton Market Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc
  • Eagle Genomics Ltd
  • F Hoffmann-La Roche AG
  • Nanostring Technologies
  • Pfizer Inc
The publisher predicts that the global market for precision medicine would observe a CAGR of 9.79% over the considered period 2021-2028.

The high prevalence of chronic diseases among the aging population is majorly driving the growth of the studied market. Furthermore, investments by government and private players in the field of cancer and demand for preventive care are generating lucrative opportunities for the precision medicine market. Here, the advancements in technologies have increased awareness regarding personal health, which has led to the rise in demand for preventive care among people.



However, certain factors, such as the stringent drug approval process, along with security threats associated with data sharing, are hindering the overall progress of the precision medicine market.

REGIONAL OUTLOOK

The global precision medicine market encompasses the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.
The Asia-Pacific is anticipated to showcase the fastest growth rate in the global market over the estimated period. The region's robust growth is primarily due to the surge in healthcare awareness coupled with advanced diagnosis methods. Additionally, numerous advanced human genome libraries produce ethnicity-specific sequences helping scientists to use genetic information to enhance precision medicine research.

Furthermore, the growing need for sequencing technologies due to the rise in the prevalence of diseases has increased the demand for genome mapping programs. Such developments are expected to support the precision medicine market's future growth in the APAC region.

COMPETITIVE OUTLOOK

The enterprises engaged in the precision medicine market are F Hoffmann-La Roche AG, Eagle Genomics Ltd, Eli Lilly & Company, Pfizer Inc, Intomics, Bio-Rad Laboratories Inc, Nanostring Technologies, Novartis AG, Laboratory Corporation of America Holdings, Biocrates Life Sciences AG, Quest Diagnostics Incorporated, Abbott Laboratories, AstraZeneca Plc, Qiagen NV, and Danaher Corporation.
Abbott Laboratories is a pharmaceutical company engaged in manufacturing and marketing a wide range of healthcare products. It provides diagnostic systems, neuromodulation devices, pediatric, and nutritional products. Additionally, it gives products under numerous brand names, including HeartMate, Heptral, and Oxepa. Founded in 1944, Abbott has a global presence across various countries. It is headquartered in the United States.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc
  • Eagle Genomics Ltd
  • F Hoffmann-La Roche AG
  • Nanostring Technologies
  • Pfizer Inc
1. Global Precision Medicine Market - Summary

2. Industry Outlook
2.1. Key Insights
2.1.1. Presence of Biopharmaceutical Companies
2.1.2. Investments in Gene Therapy
2.2. Impact of COVID-19 on Precision Medicine Market
2.3. Supply Chain Outlook
2.4. Regulatory Policies & Framework
2.5. Etymology of Precision Medicine
2.6. Porter's Five Forces Model
2.7. Market Attractiveness Index
2.8. Vendor Landscape
2.9. Key Market Strategies
2.9.1. Contracts and Partnerships
2.9.2. Business Expansion & Divestitures
2.9.3. Acquisitions & Mergers
2.9.4. New Product Launches
2.10. Market Drivers
2.10.1. High Prevalence of Chronic Diseases in the Aging Population
2.10.2. Digital Collaboration Among Research Groups and Organizations
2.10.3. Identification of Genetic Makeup in the Human Genome
2.11. Market Challenges
2.11.1. Stringent Drug Approval Process
2.11.2. Security Threats Pertaining to Data Sharing
2.11.3. Changes in Reimbursement and Regulatory Process
2.12. Market Opportunities
2.12.1. Investments by Government and Private Players in Cancer Treatment
2.12.2. Demand for Preventive Care

3. Global Precision Medicine Market - by Application
3.1. Oncology
3.2. Infectious Diseases
3.3. Neurology/Physiatry
3.4. Cardiovascular
3.5. Lifestyle and Endocrinology
3.6. Gastroenterology
3.7. Other Applications

4. Global Precision Medicine Market - by Component
4.1. Applied Science
4.1.1. Genomics
4.1.1.1. Pcr
4.1.1.2. Pm Ngs
4.1.1.3. Genome Editing
4.1.1.4. Other Genomics Technologies
4.1.2. Pharmacogenomics
4.1.3. Other Applied Sciences
4.2. Precision Therapeutics
4.2.1. Clinical Trials
4.2.2. Cell Therapy
4.2.3. Drug Discovery and Research
4.2.4. Gene Therapy
4.3. Precision Diagnostics
4.3.1. Molecular Diagnostics
4.3.1.1. Non-Invasive Prenatal Testing (Nipt)
4.3.1.2. Companion Diagnostics
4.3.1.3. Liquid Biopsy
4.3.1.4. Other Molecular Diagnostics
4.3.2. Medical Imaging
4.3.2.1. Imaging Analytics
4.3.2.2. Imaging Computer-Aided Detection (Cadx)
4.4. Digital Health and Information Technology
4.4.1. Clinical Decision Support Systems (Cdss)
4.4.2. Big Data Analytics
4.4.3. It Infrastructure
4.4.4. Genomics Informatics
4.4.5. In-Silico Informatics
4.4.6. Mobile Health

5. Global Precision Medicine Market – Regional Outlook
5.1. North America
5.1.1. Market by Application
5.1.2. Market by Component
5.1.2.1. Applied Science Market by Type
5.1.2.1.1. Genomics Market by Type
5.1.2.2. Precision Therapeutics Market by Type
5.1.2.3. Precision Diagnostics Market by Type
5.1.2.3.1. Molecular Diagnostics Market by Type
5.1.2.3.2. Medical Imaging Market by Type
5.1.2.4. Digital Health and Information Technology Market by Type
5.1.3. Country Analysis
5.1.3.1. United States
5.1.3.2. Canada
5.2. Europe
5.2.1. Market by Application
5.2.2. Market by Component
5.2.2.1. Applied Science Market by Type
5.2.2.1.1. Genomics Market by Type
5.2.2.2. Precision Therapeutics Market by Type
5.2.2.3. Precision Diagnostics Market by Type
5.2.2.3.1. Molecular Diagnostics Market by Type
5.2.2.3.2. Medical Imaging Market by Type
5.2.2.4. Digital Health and Information Technology Market by Type
5.2.3. Country Analysis
5.2.3.1. Germany
5.2.3.2. France
5.2.3.3. United Kingdom
5.2.3.4. Italy
5.2.3.5. Russia
5.2.3.6. Spain
5.2.3.7. Rest of Europe
5.3. Asia-Pacific
5.3.1. Market by Application
5.3.2. Market by Component
5.3.2.1. Applied Science Market by Type
5.3.2.1.1. Genomics Market by Type
5.3.2.2. Precision Therapeutics Market by Type
5.3.2.3. Precision Diagnostics Market by Type
5.3.2.3.1. Molecular Diagnostics Market by Type
5.3.2.3.2. Medical Imaging Market by Type
5.3.2.4. Digital Health and Information Technology Market by Type
5.3.3. Country Analysis
5.3.3.1. China
5.3.3.2. Japan
5.3.3.3. Australia & New Zealand
5.3.3.4. India
5.3.3.5. South Korea
5.3.3.6. Asean Countries
5.3.3.7. Rest of Asia-Pacific
5.4. Latin America
5.4.1. Market by Application
5.4.2. Market by Component
5.4.2.1. Applied Science Market by Type
5.4.2.1.1. Genomics Market by Type
5.4.2.2. Precision Therapeutics Market by Type
5.4.2.3. Precision Diagnostics Market by Type
5.4.2.3.1. Molecular Diagnostics Market by Type
5.4.2.3.2. Medical Imaging Market by Type
5.4.2.4. Digital Health and Information Technology Market by Type
5.4.3. Country Analysis
5.4.3.1. Mexico
5.4.3.2. Brazil
5.4.3.3. Rest of Latin America
5.5. Middle East and Africa
5.5.1. Market by Application
5.5.2. Market by Component
5.5.2.1. Applied Science Market by Type
5.5.2.1.1. Genomics Market by Type
5.5.2.2. Precision Therapeutics Market by Type
5.5.2.3. Precision Diagnostics Market by Type
5.5.2.3.1. Molecular Diagnostics Market by Type
5.5.2.3.2. Medical Imaging Market by Type
5.5.2.4. Digital Health and Information Technology Market by Type
5.5.3. Country Analysis
5.5.3.1. Saudi Arabia
5.5.3.2. United Arab Emirates
5.5.3.3. Turkey
5.5.3.4. South Africa
5.5.3.5. Rest of Middle East & Africa

6. Competitive Landscape
6.1. Abbott Laboratories
6.2. Astrazeneca plc
6.3. Biocrates Life Sciences AG
6.4. Bio-Rad Laboratories Inc
6.5. Danaher Corporation
6.6. Eagle Genomics Ltd
6.7. Eli Lilly & Company
6.8. F Hoffmann-La Roche AG
6.9. Intomics
6.10. Laboratory Corporation of America Holdings
6.11. Nanostring Technologies
6.12. Novartis AG
6.13. Pfizer Inc
6.14. Qiagen Nv
6.15. Quest Diagnostics Incorporated

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.1.2. Scope of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List of Tables
Table 1: Global Precision Medicine Market, Regional Outlook, 2021-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Landscape
Table 4: List of Contracts & Partnerships
Table 5: List of Business Expansions & Divestitures
Table 6: List of Acquisitions & Mergers
Table 7: List of New Product Launches
Table 8: Global Precision Medicine Market, by Application, 2021-2028 (In $ Million)
Table 9: Global Precision Medicine Market, by Component, 2021-2028 (In $ Million)
Table 10: Global Applied Science Market, by Type, 2021-2028 (In $ Million)
Table 11: Global Genomics Market, by Type, 2021-2028 (In $ Million)
Table 12: Global Precision Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 13: Global Precision Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 14: Global Molecular Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 15: Global Medical Imaging Market, by Type, 2021-2028 (In $ Million)
Table 16: Global Digital Health and Information Technology Market, by Type, 2021-2028 (In $ Million)
Table 17: Global Precision Medicine Market, by Region, 2021-2028 (In $ Million)
Table 18: North America Precision Medicine Market, by Country, 2021-2028 (In $ Million)
Table 19: North America Precision Medicine Market, by Application, 2021-2028 (In $ Million)
Table 20: North America Precision Medicine Market, by Component, 2021-2028 (In $ Million)
Table 21: North America Applied Science Market, by Type, 2021-2028 (In $ Million)
Table 22: North America Genomics Market, by Type, 2021-2028 (In $ Million)
Table 23: North America Precision Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 24: North America Precision Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 25: North America Molecular Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 26: North America Medical Imaging Market, by Type, 2021-2028 (In $ Million)
Table 27: North America Digital Health and Information Technology Market, by Type, 2021-2028 (In $ Million)
Table 28: Europe Precision Medicine, by Country, 2021-2028 (In $ Million)
Table 29: Europe Precision Medicine Market, by Application, 2021-2028 (In $ Million)
Table 30: Europe Precision Medicine Market, by Component, 2021-2028 (In $ Million)
Table 31: Europe Applied Science Market, by Type, 2021-2028 (In $ Million)
Table 32: Europe Genomics Market, by Type, 2021-2028 (In $ Million)
Table 33: Europe Precision Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 34: Europe Precision Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 35: Europe Molecular Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 36: Europe Medical Imaging Market, by Type, 2021-2028 (In $ Million)
Table 37: Europe Digital Health and Information Technology Market, by Type, 2021-2028 (In $ Million)
Table 38: Asia-Pacific Precision Medicine Market, by Country, 2021-2028 (In $ Million)
Table 39: Asia-Pacific Precision Medicine Market, by Application, 2021-2028 (In $ Million)
Table 40: Asia-Pacific Precision Medicine Market, by Component, 2021-2028 (In $ Million)
Table 41: Asia-Pacific Applied Science Market, by Type, 2021-2028 (In $ Million)
Table 42: Asia-Pacific Genomics Market, by Type, 2021-2028 (In $ Million)
Table 43: Asia-Pacific Precision Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 44: Asia-Pacific Precision Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 45: Asia-Pacific Molecular Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 46: Asia-Pacific Medical Imaging Market, by Type, 2021-2028 (In $ Million)
Table 47: Asia-Pacific Digital Health and Information Technology Market, by Type, 2021-2028 (In $ Million)
Table 48: Latin America Precision Medicine Market, by Application, 2021-2028 (In $ Million)
Table 49: Latin America Precision Medicine Market, by Component, 2021-2028 (In $ Million)
Table 50: Latin America Applied Science Market, by Type, 2021-2028 (In $ Million)
Table 51: Latin America Genomics Market, by Type, 2021-2028 (In $ Million)
Table 52: Latin America Precision Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 53: Latin America Precision Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 54: Latin America Molecular Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 55: Latin America Medical Imaging Market, by Type, 2021-2028 (In $ Million)
Table 56: Latin America Digital Health and Information Technology Market, by Type, 2021-2028 (In $ Million)
Table 57: Rest of Latin America Precision Medicine Market, by Country, 2021-2028 (In $ Million)
Table 58: Middle East and Africa Precision Medicine Market, by Country, 2021-2028 (In $ Million)
Table 59: Middle East and Africa Precision Medicine Market, by Application, 2021-2028 (In $ Million)
Table 60: Middle East and Africa Precision Medicine Market, by Component, 2021-2028 (In $ Million)
Table 61: Middle East and Africa Applied Science Market, by Type, 2021-2028 (In $ Million)
Table 62: Middle East and Africa Genomics Market, by Type, 2021-2028 (In $ Million)
Table 63: Middle East and Africa Precision Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 64: Middle East and Africa Precision Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 65: Middle East and Africa Molecular Diagnostics Market, by Type, 2021-2028 (In $ Million)
Table 66: Middle East and Africa Medical Imaging Market, by Type, 2021-2028 (In $ Million)
Table 67: Middle East and Africa Digital Health and Information Technology Market, by Type, 2021-2028 (In $ Million)

List of Figures
Figure 1: Global Precision Medicine Market, Regional Outlook, 2021-2028 (In $ Million)
Figure 2: Global Precision Medicine Market, by Application, 2020 & 2028
Figure 3: Global Precision Medicine Market, by Oncology, 2021-2028 (In $ Million)
Figure 4: Global Precision Medicine Market, by Infectious Diseases, 2021-2028 (In $ Million)
Figure 5: Global Precision Medicine Market, by Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 6: Global Precision Medicine Market, by Cardiovascular, 2021-2028 (In $ Million)
Figure 7: Global Precision Medicine Market, by Lifestyle and Endocrinology, 2021-2028 (In $ Million)
Figure 8: Global Precision Medicine Market, by Gastroenterology, 2021-2028 (In $ Million)
Figure 9: Global Precision Medicine Market, by Other Applications, 2021-2028 (In $ Million)
Figure 10: Global Precision Medicine Market, by Component, 2020 & 2028
Figure 11: Global Precision Medicine Market, by Applied Science, 2021-2028 (In $ Million)
Figure 12: Global Applied Science Market, by Genomics, 2021-2028 (In $ Million)
Figure 13: Global Genomics Market, by Pcr, 2021-2028 (In $ Million)
Figure 14: Global Genomics Market, by Pm Ngs, 2021-2028 (In $ Million)
Figure 15: Global Genomics Market, by Genome Editing, 2021-2028 (In $ Million)
Figure 16: Global Genomics Market, Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 17: Global Applied Science Market, by Pharmacogenomics, 2021-2028 (In $ Million)
Figure 18: Biomarkers Role in Pharmacogenomics
Figure 19: Global Applied Science Market, by Other Applied Sciences, 2021-2028 (In $ Million)
Figure 20: Global Precision Medicine Market, by Precision Therapeutics, 2021-2028 (In $ Million)
Figure 21: Global Precision Therapeutics Market, by Clinical Trials, 2021-2028 (In $ Million)
Figure 22: Global Precision Therapeutics Market, by Cell Therapy, 2021-2028 (In $ Million)
Figure 23: Global Precision Therapeutics Market, by Drug Discovery and Research, 2021-2028 (In $ Million)
Figure 24: Global Precision Therapeutics Market, by Gene Therapy, 2021-2028 (In $ Million)
Figure 25: Global Precision Medicine Market, by Precision Diagnostics, 2021-2028 (In $ Million)
Figure 26: Global Precision Diagnostics Market, by Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 27: Global Molecular Diagnostics Market, by Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 28: Global Molecular Diagnostics Market, by Companion Diagnostics, 2021-2028 (In $ Million)
Figure 29: Global Molecular Diagnostics Market, by Liquid Biopsy, 2021-2028 (In $ Million)
Figure 30: Global Molecular Diagnostics Market, by Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 31: Global Precision Diagnostics Market, by Medical Imaging, 2021-2028 (In $ Million)
Figure 32: Global Medical Imaging Market, by Imaging Analytics, 2021-2028 (In $ Million)
Figure 33: Global Medical Imaging Market, by Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 34: Global Precision Medicine Market, by Digital Health and Information Technology, 2021-2028 (In $ Million)
Figure 35: Global Digital Health and Information Technology Market, by Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 36: Global Digital Health and Information Technology Market, by Big Data Analytics, 2021-2028 (In $ Million)
Figure 37: Global Digital Health and Information Technology Market, by It Infrastructure, 2021-2028 (In $ Million)
Figure 38: Global Digital Health and Information Technology Market, by Genomics Informatics, 2021-2028 (In $ Million)
Figure 39: Global Digital Health and Information Technology Market, by In-Silico Informatics, 2021-2028 (In $ Million)
Figure 40: Global Digital Health and Information Technology Market, by Mobile Health, 2021-2028 (In $ Million)
Figure 41: Global Precision Medicine Market, by Region, 2020 & 2028
Figure 42: United States Precision Medicine Market 2021-2028 (In $ Million)
Figure 43: Canada Precision Medicine Market 2021-2028 (In $ Million)
Figure 44: Germany Precision Medicine Market 2021-2028 (In $ Million)
Figure 45: France Precision Medicine Market 2021-2028 (In $ Million)
Figure 46: United Kingdom Precision Medicine Market 2021-2028 (In $ Million)
Figure 47: Italy Precision Medicine Market 2021-2028 (In $ Million)
Figure 48: Russia Precision Medicine Market 2021-2028 (In $ Million)
Figure 49: Spain Precision Medicine Market 2021-2028 (In $ Million)
Figure 50: Rest of Europe Precision Medicine Market 2021-2028 (In $ Million)
Figure 51: China Precision Medicine Market 2021-2028 (In $ Million)
Figure 52: Japan Precision Medicine Market 2021-2028 (In $ Million)
Figure 53: Australia & New Zealand Precision Medicine Market 2021-2028 (In $ Million)
Figure 54: India Precision Medicine Market 2021-2028 (In $ Million)
Figure 55: South Korea Precision Medicine Market 2021-2028 (In $ Million)
Figure 56: Asean Countries Precision Medicine Market 2021-2028 (In $ Million)
Figure 57: Rest of Asia-Pacific Precision Medicine Market 2021-2028 (In $ Million)
Figure 58: Latin America Precision Medicine Market 2021-2028 (In $ Million)
Figure 59: Mexico Precision Medicine Market 2021-2028 (In $ Million)
Figure 60: Brazil Precision Medicine Market 2021-2028 (In $ Million)
Figure 61: Rest of Latin America Precision Medicine Market 2021-2028 (In $ Million)
Figure 62: Saudi Arabia Precision Medicine Market 2021-2028 (In $ Million)
Figure 63: United Arab Emirates Precision Medicine Market 2021-2028 (In $ Million)
Figure 64: Turkey Precision Medicine Market 2021-2028 (In $ Million)
Figure 65: South Africa Precision Medicine Market 2021-2028 (In $ Million)
Figure 66: Rest of Middle East & Africa Precision Medicine Market 2021-2028 (In $ Million)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Astrazeneca plc
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • Eagle Genomics Ltd
  • Eli Lilly & Company
  • F Hoffmann-La Roche AG
  • Intomics
  • Laboratory Corporation of America Holdings
  • Nanostring Technologies
  • Novartis AG
  • Pfizer Inc
  • Qiagen Nv
  • Quest Diagnostics Incorporated
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll